
Stoke Therapeutics, Inc.
USD32.77
+0.38 (+1.17%)
CEO
Ian F. Smith
IPO Date
2019-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.90
Prev. Close
$32.39
Day Low
$32.50
Day High
$33.10
52W Low
$11.19
52W High
$40.22
Market Cap
$2.04B
Volume
0.17M
| Chardan Capital |
| Buy |
| Buy |
| maintain |
| 18 Mar 2026 | Wedbush | Outperform | Outperform | maintain |
| 17 Mar 2026 | Wedbush | Outperform | Outperform | maintain |
| 17 Mar 2026 | Needham | Buy | Buy | maintain |
| 12 Jan 2026 | Wedbush | Outperform | Outperform | maintain |
| 5 Jan 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 5 Jan 2026 | Chardan Capital | Buy | Buy | maintain |